Page last updated: 2024-11-08

pentylenetetrazole and Gelineau Syndrome

pentylenetetrazole has been researched along with Gelineau Syndrome in 2 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROTH, B1
Kazamatsuri, H1

Other Studies

2 other studies available for pentylenetetrazole and Gelineau Syndrome

ArticleYear
The influence of cardiazol and psychoton on the EEG in narcolepsy.
    Chekhoslovatskaia fiziologiia, 1954, Volume: 3, Issue:4

    Topics: Amphetamine; Amphetamines; Electroencephalography; Humans; Narcolepsy; Pentylenetetrazole; Sleep Wak

1954
EEG activation with Dimefline hydrochloride.
    Folia psychiatrica et neurologica japonica, 1969, Volume: 23, Issue:1

    Topics: Adolescent; Adult; Alcoholism; Central Nervous System Stimulants; Craniocerebral Trauma; Electroence

1969